Regulation at non-saturating levels of TF. by Md Zulfikar Ali (11965544)

Table2_Benchmarking microbial DNA enrichment protocols from human intestinal biopsies.XLSX by Dmitrij Marchukov (15356863)

“…Additional optimization steps using further detergents and bead-beating steps improved the efficacy of less efficient protocols but not of the QIAamp kit. …”

Table2_Benchmarking microbial DNA enrichment protocols from human intestinal biopsies.XLSX by Dmitrij Marchukov (15356863)

“…Additional optimization steps using further detergents and bead-beating steps improved the efficacy of less efficient protocols but not of the QIAamp kit. …”

Data_Sheet_2_Force and Stepwise Movements of Gliding Motility in Human Pathogenic Bacterium Mycoplasma pneumoniae.XLSX by Masaki Mizutani (11476414)

“…The step size was reduced to less than half with the load applied using optical tweezers, showing that a 2.5 pN force from a cell is exerted on a leg. …”

Comparison of <i>Killer-Rescue</i> and split <i>ClvR</i> genetics. by Georg Oberhofer (3401438)

Diameter at breast height (DBH) versus time for select trees from the different studies to highlight the variety of responses observed. by Brian J. Mailloux (190217)

Image2_Distal weight bearing in transtibial prosthesis users wearing pin suspension.pdf by Adam J. Krout (17686743)

“…</p>Discussion<p>Next steps in this research are to develop clinical practices to determine target distal weight bearing levels and ranges, and to simplify the design of the sensor and weight bearing adjustment mechanism for clinical use.…”

Presentation2_Distal weight bearing in transtibial prosthesis users wearing pin suspension.pdf by Adam J. Krout (17686743)

“…</p>Discussion<p>Next steps in this research are to develop clinical practices to determine target distal weight bearing levels and ranges, and to simplify the design of the sensor and weight bearing adjustment mechanism for clinical use.…”

Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Data Sheet 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”

Data_Sheet_2_Cognitive Motivation as a Resource for Affective Adjustment and Mental Health.pdf by Alexander Strobel (5898266)

“…Data were split and analyzed in two steps: We tested previously reported cross-sectional and longitudinal associations of all variables as well as their longitudinal changes in a first sample. …”

Gonadal development and sex ratios as a function of TL. by Frederic H. Martini (481487)

“…</p> <p>(b) Sex ratios (female:male) as a function of TL. Data were sorted into 50 mm TL intervals. …”

Context and impact of elevated antisense expression levels in the Δ<i>rho</i> mutant. by Ulrike Mäder (205299)

“…Each annotated gene is represented by a point. There is a strong negative correlation between sense and antisense expression in the Δ<i>rho</i> mutant (Pearson correlation coefficient r = -0.73) that is also visible but much weaker in the wild-type (r = -0.30). …”

AzEvC10 mutant hypervirulence is caused by an RNase E mutation. by Mylene Vaillancourt (7409486)

Genetic analysis of Japanese primary open-angle glaucoma patients and clinical characterization of risk alleles near <i>CDKN2B-AS1</i>, <i>SIX6</i> and <i>GAS7</i> by Yukihiro Shiga (724428)

“…The genotype–phenotype analysis revealed significant correlations between <i>CDKN2B-AS1</i> (rs2157719) and decreased intraocular pressure (β = -6.89 mmHg, <i>P</i> = 1.70E-04; dominant model) after multiple corrections. …”

Heatmaps with different genetic linkage and migration rate. by Georg Oberhofer (3401438)

“…<p>Heatmaps showing the average <i>Rescue</i> frequency for 100 <b>(A-C)</b> and 300 generations <b>(D-F)</b>. Linkage ranging from 0–50 cM, migration rate from 0.1–20% per generation. …”

A case of retroperitoneal fibrosis responding to steroid therapy by Ryuta Watanabe (4748580)